Venous thromboembolism (VTE), including deep‐vein thrombosis and pulmonary embolism,
represents a major cause of morbidity and mortality in cancer patients. Patients with cancer …

Venous thromboembolism (VTE) is a major preventable disease that affects hospitalized
inpatients. Risk stratification and prophylactic measures have good evidence supporting …

Thromboembolism in people with cancer still remains a major health problem and is a
leading cause of mortality after cancer itself, despite being a largely preventable disease. 1 …

Background Venous thromboembolism (VTE) represents a leading cause of morbidity and
mortality among patients with cancer. Methods Hospitalization data reported on adult cancer …

Venous and arterial thromboembolism are prevalent, highly burdensome, and associated
with risk of worse outcomes for patients with cancer. Risk for venous thromboembolism …

Introduction Venous thromboembolism (VTE) is a leading cause of cardiovascular morbidity
and mortality. The majority of VTE events are hospital‐associated. In 2008, the …

Abstract Background The Khorana score (KS) clinical algorithm is used to predict VTE risk in
cancer patients. The study objective was to evaluate VTE and survival rates among patients …

Background & Aims Pancreatic ductal adenocarcinoma (PDAC) is associated with the
highest incidence of venous thromboembolism (VTE) of any cancer type. However, little is …

Lymphoma patients are at increased risk of thromboembolic events but thromboprophylaxis
in these patients is largely underused. We sought to develop and validate a simple model …

Inpatient venous thromboembolism (VTE) is a priority preventable illness; risk in cancer
varies and prophylaxis is inconsistently used. A previously validated tool (Khorana …